Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 322

1.

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis.

Wottschel V, Chard DT, Enzinger C, Filippi M, Frederiksen JL, Gasperini C, Giorgio A, Rocca MA, Rovira A, De Stefano N, Tintoré M, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group and the EuroPOND consortium.

Neuroimage Clin. 2019 Oct 22;24:102011. doi: 10.1016/j.nicl.2019.102011. [Epub ahead of print]

2.

Response to Dr Boyko's letter: 'Radiologically isolated syndrome with oligoclonal bands in CSF (RIS + OCB) can be classified as highly MS-risk group'.

de Stefano N.

Mult Scler. 2019 Oct 18:1352458519881987. doi: 10.1177/1352458519881987. [Epub ahead of print] No abstract available.

PMID:
31625808
3.

Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment.

Pantoni L, Marzi C, Poggesi A, Giorgio A, De Stefano N, Mascalchi M, Inzitari D, Salvadori E, Diciotti S.

Neuroimage Clin. 2019 Aug 22;24:101990. doi: 10.1016/j.nicl.2019.101990. [Epub ahead of print]

4.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
5.

MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.

Storelli L, Rocca MA, Pantano P, Pagani E, De Stefano N, Tedeschi G, Zaratin P, Filippi M; INNI Network.

J Neurol. 2019 Nov;266(11):2848-2858. doi: 10.1007/s00415-019-09509-4. Epub 2019 Aug 17.

PMID:
31422457
6.

Automated lesion segmentation with BIANCA: Impact of population-level features, classification algorithm and locally adaptive thresholding.

Sundaresan V, Zamboni G, Le Heron C, Rothwell PM, Husain M, Battaglini M, De Stefano N, Jenkinson M, Griffanti L.

Neuroimage. 2019 Nov 15;202:116056. doi: 10.1016/j.neuroimage.2019.116056. Epub 2019 Jul 31.

7.

Exploring the role of music therapy in multiple sclerosis: brief updates from research to clinical practice.

Vinciguerra C, De Stefano N, Federico A.

Neurol Sci. 2019 Nov;40(11):2277-2285. doi: 10.1007/s10072-019-04007-x. Epub 2019 Jul 12.

PMID:
31300912
8.

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA.

Brain. 2019 Jul 1;142(7):1858-1875. doi: 10.1093/brain/awz144.

9.

Lifespan normative data on rates of brain volume changes.

Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, Filippi M, Rocca MA, Preziosa P, Gallo A, Bisecco A, Palace J, Kong Y, Horakova D, Vaneckova M, Gasperini C, Ruggieri S, De Stefano N; MAGNIMS Study Group.

Neurobiol Aging. 2019 Sep;81:30-37. doi: 10.1016/j.neurobiolaging.2019.05.010. Epub 2019 May 22.

PMID:
31207467
10.

Relevance of brain lesion location for cognition in vascular mild cognitive impairment.

Giorgio A, Di Donato I, De Leucio A, Zhang J, Salvadori E, Poggesi A, Diciotti S, Cosottini M, Ciulli S, Inzitari D, Pantoni L, Mascalchi M, Federico A, Dotti MT, De Stefano N; VMCI-Tuscany Study Group.

Neuroimage Clin. 2019;22:101789. doi: 10.1016/j.nicl.2019.101789. Epub 2019 Mar 23.

11.

Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.

d'Ambrosio A, Valsasina P, Gallo A, De Stefano N, Pareto D, Barkhof F, Ciccarelli O, Enzinger C, Tedeschi G, Stromillo ML, Arévalo MJ, Hulst HE, Muhlert N, Koini M, Filippi M, Rocca MA.

Mult Scler. 2019 Mar 19:1352458519837707. doi: 10.1177/1352458519837707. [Epub ahead of print]

PMID:
30887862
12.

How much do periventricular lesions assist in distinguishing migraine with aura from CIS?

Lapucci C, Saitta L, Bommarito G, Sormani MP, Pardini M, Bonzano L, Mancardi GL, Gasperini C, Giorgio A, Inglese M, De Stefano N, Roccatagliata L.

Neurology. 2019 Apr 9;92(15):e1739-e1744. doi: 10.1212/WNL.0000000000007266. Epub 2019 Mar 8.

PMID:
30850445
13.

Changes in grey matter volume and functional connectivity in cluster headache versus migraine.

Giorgio A, Lupi C, Zhang J, De Cesaris F, Alessandri M, Mortilla M, Federico A, Geppetti P, De Stefano N, Benemei S.

Brain Imaging Behav. 2019 Feb 14. doi: 10.1007/s11682-019-00046-2. [Epub ahead of print]

PMID:
30762158
14.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

15.

Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis.

Vinciguerra C, Giorgio A, Zhang J, Di Donato I, Stromillo ML, Tappa Brocci R, Federico A, Dotti MT, De Stefano N.

Mult Scler Relat Disord. 2019 Jan;27:294-297. doi: 10.1016/j.msard.2018.11.011. Epub 2018 Nov 13.

PMID:
30448470
16.

Learning ability correlates with brain atrophy and disability progression in RRMS.

Sormani MP, De Stefano N, Giovannoni G, Langdon D, Piani-Meier D, Haering DA, Kappos L, Tomic D.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):38-43. doi: 10.1136/jnnp-2018-319129. Epub 2018 Oct 15.

17.

The dilemma of benign multiple sclerosis: Can we predict the risk of losing the "benign status"? A 12-year follow-up study.

Razzolini L, Portaccio E, Stromillo ML, Goretti B, Niccolai C, Pastò L, Righini I, Prestipino E, Battaglini M, Giorgio A, De Stefano N, Amato MP.

Mult Scler Relat Disord. 2018 Nov;26:71-73. doi: 10.1016/j.msard.2018.08.011. Epub 2018 Aug 18.

PMID:
30237106
18.

Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.

Bonzano L, Bove M, Sormani MP, Stromillo ML, Giorgio A, Amato MP, Tacchino A, Mancardi GL, De Stefano N.

Eur J Neurol. 2019 Jan;26(1):162-167. doi: 10.1111/ene.13789. Epub 2018 Sep 24. Erratum in: Eur J Neurol. 2019 May;26(5):830.

PMID:
30133054
19.

Blood-brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations.

Taglia I, Di Donato I, De Stefano N, Bianchi S, Galluzzi P, Federico A, Dotti MT.

Eur J Neurol. 2018 Aug;25(8):e86-e87. doi: 10.1111/ene.13656. No abstract available.

PMID:
29984895
20.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

21.

DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study.

Mascalchi M, Salvadori E, Toschi N, Giannelli M, Orsolini S, Ciulli S, Ginestroni A, Poggesi A, Giorgio A, Lorenzini F, Pasi M, De Stefano N, Pantoni L, Inzitari D, Diciotti S; VMCI-Tuscany study group.

Brain Imaging Behav. 2019 Jun;13(3):594-602. doi: 10.1007/s11682-018-9873-5.

PMID:
29744799
22.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

23.

Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.

Storelli L, Rocca MA, Pagani E, Van Hecke W, Horsfield MA, De Stefano N, Rovira A, Sastre-Garriga J, Palace J, Sima D, Smeets D, Filippi M; MAGNIMS Study Group.

Radiology. 2018 Aug;288(2):554-564. doi: 10.1148/radiol.2018172468. Epub 2018 May 1.

PMID:
29714673
24.

Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients.

Salvadori E, Poggesi A, Pracucci G, Chiti A, Ciolli L, Cosottini M, Del Bene A, De Stefano N, Diciotti S, Di Donato I, Ginestroni A, Marini S, Mascalchi M, Nannucci S, Orlandi G, Pasi M, Pescini F, Valenti R, Federico A, Dotti MT, Bonuccelli U, Inzitari D, Pantoni L; VMCI-Tuscany Study Group.

Dement Geriatr Cogn Dis Extra. 2018 Mar 29;8(1):104-116. doi: 10.1159/000487130. eCollection 2018 Jan-Apr.

25.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
26.

Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.

Opfer R, Ostwaldt AC, Walker-Egger C, Manogaran P, Sormani MP, De Stefano N, Schippling S.

J Neurol. 2018 May;265(5):1158-1165. doi: 10.1007/s00415-018-8825-8. Epub 2018 Mar 16.

PMID:
29549466
27.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
28.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440
29.

Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model.

Rigo F, De Stefano N, Navarro-Tableros V, David E, Rizza G, Catalano G, Gilbo N, Maione F, Gonella F, Roggio D, Martini S, Patrono D, Salizzoni M, Camussi G, Romagnoli R.

Transplantation. 2018 May;102(5):e205-e210. doi: 10.1097/TP.0000000000002123.

PMID:
29424767
30.

Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults.

Opfer R, Ostwaldt AC, Sormani MP, Gocke C, Walker-Egger C, Manogaran P, De Stefano N, Schippling S.

Neurobiol Aging. 2018 May;65:1-6. doi: 10.1016/j.neurobiolaging.2017.12.024. Epub 2017 Dec 30.

PMID:
29407463
31.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

32.

Response to 'Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?' by Schiffmann et al.

De Stefano N, Giorgio A.

Mult Scler. 2018 Sep;24(10):1388-1389. doi: 10.1177/1352458517748476. Epub 2018 Jan 8. No abstract available.

PMID:
29308979
33.

SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.

Battaglini M, Jenkinson M, De Stefano N; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2018 Mar;39(3):1063-1077. doi: 10.1002/hbm.23828. Epub 2017 Dec 8.

PMID:
29222814
34.

Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability.

Giorgio A, Zhang J, Stromillo ML, Rossi F, Battaglini M, Nichelli L, Mortilla M, Portaccio E, Hakiki B, Amato MP, De Stefano N.

Front Neurol. 2017 Nov 14;8:608. doi: 10.3389/fneur.2017.00608. eCollection 2017.

35.

Effective Utilization of MRI in the Diagnosis and Management of Multiple Sclerosis.

Giorgio A, De Stefano N.

Neurol Clin. 2018 Feb;36(1):27-34. doi: 10.1016/j.ncl.2017.08.013. Review.

PMID:
29157402
36.

Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.

Bovis F, De Stefano N, Steinerman JR, Knappertz V, Sormani MP.

Mult Scler. 2019 Feb;25(2):217-223. doi: 10.1177/1352458517743804. Epub 2017 Nov 20.

PMID:
29154721
37.

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.

Uher T, Vaneckova M, Krasensky J, Sobisek L, Tyblova M, Volna J, Seidl Z, Bergsland N, Dwyer MG, Zivadinov R, De Stefano N, Sormani MP, Havrdova EK, Horakova D.

Mult Scler. 2019 Apr;25(4):541-553. doi: 10.1177/1352458517742739. Epub 2017 Nov 16.

PMID:
29143562
38.

Diffuse brain damage in normal tension glaucoma.

Giorgio A, Zhang J, Costantino F, De Stefano N, Frezzotti P.

Hum Brain Mapp. 2018 Jan;39(1):532-541. doi: 10.1002/hbm.23862. Epub 2017 Oct 24.

PMID:
29064608
39.

Imaging outcome measures for progressive multiple sclerosis trials.

Moccia M, de Stefano N, Barkhof F.

Mult Scler. 2017 Oct;23(12):1614-1626. doi: 10.1177/1352458517729456. Review. Erratum in: Mult Scler. 2018 Feb;24(2):NP32.

40.

Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO.

Sormani MP, Truffinet P, Thangavelu K, Rufi P, Simonson C, De Stefano N.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 28;4(5):e379. doi: 10.1212/NXI.0000000000000379. eCollection 2017 Sep.

41.

Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials - Commentary.

De Stefano N, Giorgio A.

Mult Scler. 2017 Oct;23(11):1458-1460. doi: 10.1177/1352458517717812. Epub 2017 Jun 30. No abstract available.

PMID:
28664817
42.

Functional Evaluation of Awareness in Vegetative and Minimally Conscious State.

Marino S, Bonanno L, Ciurleo R, Baglieri A, Morabito R, Guerrera S, Rifici C, Giorgio A, Bramanti P, De Stefano N.

Open Neuroimag J. 2017 Apr 27;11:17-25. doi: 10.2174/1874440001711010017. eCollection 2017.

43.

Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Carluccio MA, Di Donato I, Pescini F, Battaglini M, Bianchi S, Valenti R, Nannucci S, Franci B, Stromillo ML, De Stefano N, Inzitari D, Pantoni L, Nuti R, Federico A, Gonnelli S, Dotti MT.

Neurol Sci. 2017 Jul;38(7):1333-1336. doi: 10.1007/s10072-017-2900-2. Epub 2017 Apr 4.

PMID:
28378255
44.

The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression.

Mignarri A, Dotti MT, Federico A, De Stefano N, Battaglini M, Grazzini I, Galluzzi P, Monti L.

J Neurol. 2017 May;264(5):862-874. doi: 10.1007/s00415-017-8440-0. Epub 2017 Mar 21.

PMID:
28324197
45.

The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS.

Filippi M, Tedeschi G, Pantano P, De Stefano N, Zaratin P, Rocca MA; INNI Network.

Neurol Sci. 2017 Jun;38(6):1029-1038. doi: 10.1007/s10072-017-2903-z. Epub 2017 Mar 14.

PMID:
28293740
46.

Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis.

De Stefano N, Silva DG, Barnett MH.

CNS Drugs. 2017 Apr;31(4):289-305. doi: 10.1007/s40263-017-0415-2. Review.

47.

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.

Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti MT, Duering M, Jouvent E, Korczyn AD, Lesnik-Oberstein SA, Malandrini A, Markus HS, Pantoni L, Penco S, Rufa A, Sinanović O, Stojanov D, Federico A.

BMC Med. 2017 Feb 24;15(1):41. doi: 10.1186/s12916-017-0778-8. Review.

48.

The role of dentate nuclei in human oculomotor control: insights from cerebrotendinous xanthomatosis.

Rosini F, Pretegiani E, Mignarri A, Optican LM, Serchi V, De Stefano N, Battaglini M, Monti L, Dotti MT, Federico A, Rufa A.

J Physiol. 2017 Jun 1;595(11):3607-3620. doi: 10.1113/JP273670. Epub 2017 Mar 14.

49.

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

De Stefano N, Giorgio A, Battaglini M, De Leucio A, Hicking C, Dangond F, Giovannoni G, Sormani MP.

Mult Scler. 2018 Feb;24(2):222-226. doi: 10.1177/1352458517690269. Epub 2017 Jan 31.

50.

Resting state fMRI regional homogeneity correlates with cognition measures in subcortical vascular cognitive impairment.

Diciotti S, Orsolini S, Salvadori E, Giorgio A, Toschi N, Ciulli S, Ginestroni A, Poggesi A, De Stefano N, Pantoni L, Inzitari D, Mascalchi M; VMCI Tuscany investigators.

J Neurol Sci. 2017 Feb 15;373:1-6. doi: 10.1016/j.jns.2016.12.003. Epub 2016 Dec 6.

PMID:
28131162

Supplemental Content

Loading ...
Support Center